Titre :
  • Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer: the LAPTEM trial.
Auteur : Azambuja, Evandro ; Zardavas, Dimitros ; Lemort, Marc ; Rossari, José ; Moulin, C ; Buttice, A ; D'Hondt, Véronique ; Lebrun, Fabienne ; Lalami, Yassine ; Cardoso, Fatima ; Sotiriou, Christos ; Gil, Thierry ; Devriendt, Daniel ; Paesmans, M ; Piccart-Gebhart, Martine ; Awada, Ahmad
Informations sur la publication : Annals of oncology, 24, 12, (page 2985-2989)
Statut de publication : Publié, 2013-12
Sujet CREF : Cancérologie
Médecine pathologie humaine
Mots-clés MeSH : Adult
Aged
Antineoplastic Combined Chemotherapy Protocols -- pharmacology -- therapeutic use
Brain Neoplasms -- drug therapy -- metabolism -- mortality -- secondary
Breast Neoplasms -- drug therapy -- metabolism -- mortality -- pathology
Dacarbazine -- administration & dosage -- analogs & derivatives
Disease-Free Survival
Female
Humans
Maximum Tolerated Dose
Middle Aged
Quinazolines -- administration & dosage
Receptor, ErbB-2 -- metabolism
Treatment Outcome
Note : Journal Article
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue :
  • Anglais
Identificateurs : urn:issn:0923-7534 
info:doi/10.1093/annonc/mdt359
info:pii/mdt359
info:pmid/24013582